Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
3.150
+0.050 (1.61%)
Dec 5, 2025, 4:00 PM EST - Market closed
Lipocine Market Cap
Lipocine has a market cap or net worth of $17.49 million as of December 5, 2025. Its market cap has decreased by -30.60% in one year.
Market Cap
17.49M
Enterprise Value
2.51M
1-Year Change
-30.60%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $17.49M, a decrease of -78.75%. That is a compound annual growth rate of -12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 17.20M | -34.10% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |